India Valve Registry Launched by Vice President

On September 4, 2026, Chennai buzzed with cardiologists, surgeons and policymakers as the India Valves 2026 summit kicked off. Amid the technical sessions, Vice‑President C. P. Radhakrishnan took the stage to launch something that could change how India fights valve disease – the India Valve Registry.

The new registry is not just a spreadsheet; it is a clinician‑led, patient‑level, longitudinal research platform that pulls data from dozens of hospitals nationwide. In the words of the Vice‑President, “Advances in cardiovascular medicine have given hope to millions, but we need our own evidence to shape treatment pathways for Indian patients.”

India’s burden of non‑communicable diseases, especially valvular and structural heart conditions, is climbing fast. The Indian Council of Medical Research flags this as a pressing public‑health challenge. By cataloguing who gets which valve intervention, how they fare over months and years, and where gaps appear, the registry aims to turn scattered clinical experience into a coherent, actionable knowledge base.

Health Minister K. G. Arunraj, representing Tamil Nadu, highlighted the state’s role as a stakeholder. He reminded the audience that the Chief Minister’s Comprehensive Health Insurance Scheme already offers cash‑less care to roughly 1.48 crore families across 2,000 empanelled hospitals. In a bold move, the Chief Minister announced in the Legislative Assembly that the annual coverage limit will jump five‑fold – from ₹5 lakh to ₹25 lakh per family – effectively pulling even high‑end cardiac procedures within reach of the poorest households.

The Tamil Nadu STEMI programme was also mentioned. It links 18 government medical‑college hub hospitals equipped with cath labs to 188 peripheral centres, creating a network that can promptly identify and treat acute cardiac events. This infrastructure, the minister said, dovetails perfectly with the registry’s goal of real‑time, data‑driven care.

Doctors at the conference were quick to note the practical benefits. Dr. Arunraj, who leads the state’s cardiac programme, said that systematic data collection will help spot regional variations, benchmark outcomes, and ultimately refine guidelines that are currently borrowed from Western studies. “We need to understand how Indian patients respond to valve repair versus replacement, especially in rural settings,” he added.

While the registry is still in its early days, the optimism in the room was palpable. As the summit continues through September 6, participants will have the chance to feed the first batch of data into the platform, laying the groundwork for a more transparent, evidence‑based future for valve disease management in India.